Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Severin Mairinger

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
Molecular Pharmaceutics|December 3, 2019
Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [<sup>11</sup>C]Tariquidar and PET in Humans and MiceIrene Hernández Lozano, Martin Bauer, Beatrix Wulkersdorfer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 21, 2020
Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [<sup>11</sup>C]erlotinibNicolas Tournier, Sebastien Goutal, Severin Mairinger, et al.
Bioorganic & Medicinal Chemistry|March 23, 2011
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance proteinBernd Dörner, Claudia Kuntner, Jens P Bankstahl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2025
Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A <sup>14</sup>C-microdosing study in healthy volunteersSeverin Mairinger, Mihye Kwon, Martin Bauer, et al.
Fluids and Barriers of the CNS|October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
Bioorganic & Medicinal Chemistry|September 12, 2016
Synthesis and preclinical characterization of 1-(6'-deoxy-6'-[<sup>18</sup>F]fluoro-β-d-allofuranosyl)-2-nitroimidazole (β-6'-[<sup>18</sup>F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxiaThomas Wanek, Katharina Kreis, Petra Križková, et al.
Journal of Medicinal Chemistry|July 11, 2015
Development of Fluorine-18 Labeled Metabolically Activated Tracers for Imaging of Drug Efflux Transporters with Positron Emission TomographyKerstin Sander, Eva Galante, Thibault Gendron, et al.
EJNMMI Research|April 20, 2016
32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016W Langsteger, A Rezaee, W Loidl, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Molecular Pharmaceutics|December 3, 2019
Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [<sup>11</sup>C]Tariquidar and PET in Humans and MiceIrene Hernández Lozano, Martin Bauer, Beatrix Wulkersdorfer, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|October 21, 2020
Complete inhibition of ABCB1 and ABCG2 at the blood-brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [<sup>11</sup>C]erlotinibNicolas Tournier, Sebastien Goutal, Severin Mairinger, et al.
Bioorganic & Medicinal Chemistry|March 23, 2011
Radiosynthesis and in vivo evaluation of 1-[18F]fluoroelacridar as a positron emission tomography tracer for P-glycoprotein and breast cancer resistance proteinBernd Dörner, Claudia Kuntner, Jens P Bankstahl, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2025
Evaluation of dose linearity in the systemic availability and pharmacokinetics of topically administered diclofenac: A <sup>14</sup>C-microdosing study in healthy volunteersSeverin Mairinger, Mihye Kwon, Martin Bauer, et al.
Fluids and Barriers of the CNS|October 28, 2024
[<sup>11</sup>C]Metoclopramide PET can detect a seizure-induced up-regulation of cerebral P-glycoprotein in epilepsy patientsMyriam El Biali, Louise Breuil, Matthias Jackwerth, et al.
Clinical and Translational Science|May 3, 2024
St. John's wort extract with a high hyperforin content does not induce P-glycoprotein activity at the human blood-brain barrierMyriam El Biali, Michael Wölfl-Duchek, Matthias Jackwerth, et al.
Bioorganic & Medicinal Chemistry|September 12, 2016
Synthesis and preclinical characterization of 1-(6'-deoxy-6'-[<sup>18</sup>F]fluoro-β-d-allofuranosyl)-2-nitroimidazole (β-6'-[<sup>18</sup>F]FAZAL) as a positron emission tomography radiotracer to assess tumor hypoxiaThomas Wanek, Katharina Kreis, Petra Križková, et al.
Journal of Medicinal Chemistry|July 11, 2015
Development of Fluorine-18 Labeled Metabolically Activated Tracers for Imaging of Drug Efflux Transporters with Positron Emission TomographyKerstin Sander, Eva Galante, Thibault Gendron, et al.
EJNMMI Research|April 20, 2016
32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016W Langsteger, A Rezaee, W Loidl, et al.
Pageof 7